CLINIGMA ApS: Financial statements 2020
CVR: 39350580
CLINIGMA ApS (CVR 39350580) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 5,329,824 and a net result of DKK 2,770,118 compared with DKK 899 the year before. That is an increase of 1,428.4% compared with the year before. Equity amounted to DKK 2,937,118. The solvency ratio was 40.3%. The company had 4 employees in the financial year.
- Gross Profit
- 5,329,824 kr.
- Profit/Loss
- 2,770,118 kr.
- Equity
- 2,937,118 kr.
- Total Assets
- 7,284,402 kr.
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 5.3 mio. | 2.8 mio. | 2.9 mio. | 4 |
| 2019 | 1.1 mio. | 349 t. | 899 | 562 t. | 2 |
| 2018 | - | 62 t. | 11 t. | 61 t. | 1 |
How creditworthy is CLINIGMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CLINIGMA ApS has published its annual report for 2019. Revenue came to DKK 1,095,538, and the net result was DKK 899.
On August 11, 2020, the company changed its name from Clinical Survey Outcomes ApS to CLINIGMA ApS.
About CLINIGMA ApS
CLINIGMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2018. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named Clinical Survey Outcomes ApS. The management consists of Christian Bredmose Holm. The company is owned by Kongsø Gruppen ApS and CH Technologies Holding ApS. In 2025, the company reported a gross profit of DKK 7,829,455 and a net result of DKK 2,200,115 compared with DKK -133,939 the year before. Equity amounted to DKK 69.
